Search Results

Bimatoprost implant reduces IOP for 2 years or more.

• Authors : Charters, Lynda

Subjects: BIMATOPROST; DRUG approval; GLAUCOMA

• Source: Ophthalmology Times. Jan2022, Vol. 47 Issue 1, p14-15. 2p.

Record details

Bimatoprost implant: Taking a holiday from glaucoma drops.

• Authors : Charters, Lynda; Bunin, Lisa

Subjects: BIMATOPROST; GLAUCOMA; CONTROLLED release drugs

• Source: Ophthalmology Times. Aug2022, Vol. 47 Issue 8, p24-24. 1p.

Record details

Sustained-release implant offers long-term IOP control, preserved visual function: Bimatoprost SR represents a paradigm shift in glaucoma treatment.

• Authors : Charters, Lynda

Subjects: CLINICAL trials; CONTROLLED release preparations; CONTROLLED release drugs

• Source: Ophthalmology Times. 3/15/2020, Vol. 45 Issue 5, p1-16. 2p.

Record details

Bimatoprost SR may offer long-term lowering of IOP: Study zeroes in on the sustained mechanism of action of the therapeutic.

• Authors : Charters, Lynda; Rhee, Douglas J.

Subjects: BIMATOPROST; INTRAOCULAR pressure; MATRIX metalloproteinasesOHIO

• Source: Ophthalmology Times. May2022, Vol. 47 Issue 5, p20-20. 1p.

Record details

Bimatoprost adherence, persistence superior in prior latanoprost users.

• Authors : Guttman Krader, Cheryl; Schwartz, Gail F.

Subjects: CLINICAL drug trials; MEDICAL protocols; GLAUCOMA

• Source: Ophthalmology Times. Feb2015, Vol. 40 Issue 2, p36-36. 1p.

Record details

Bimatoprost Topical.

• Source: ASHP Patient Medication Information - English Version. Mar2022, p1-1. 1p.

Record details

Adherence, tolerability are key in treatment of hypertension, glaucoma: Priorities can ensure optimal outcomes for patients diagnosed with diseases.

• Authors : Larsen, Christine; Ristvedt, Deborah

Subjects: GLAUCOMA surgery; CUTANEOUS therapeutics; PATIENT compliance

• Source: Ophthalmology Times. Apr2024, Vol. 49 Issue 4, p16-18. 2p.

Record details

Bimatoprost Ophthalmic.

• Source: ASHP Patient Medication Information - English Version. Mar2022, p1-1. 1p.

Record details

Bimatoprost 0.01% alters paradigm.

• Authors : Krader, Cheryl Guttman

Subjects: INTRAOCULAR pressure; TREATMENT of eye diseases; ANTIHYPERTENSIVE agents

• Source: Ophthalmology Times. Jan2011, Vol. 36 Issue 1, p18-19. 2p.

Record details

Bimatoprost insert offers noninvasive platform for early glaucoma patients.

• Authors : Gebhart, Fred; Brandt, James

Subjects: CONTROLLED release drugs; GLAUCOMA; EARLY medical intervention

• Source: Ophthalmology Times. 3/15/2017, Vol. 42 Issue 5, p24-24. 1p.

Record details